Signal Advisors Wealth’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$730K Sell
2,075
-208
-9% -$74.2K 0.05% 302
2025
Q4
$747K Sell
2,283
-791
-26% -$251K 0.06% 240
2025
Q3
$867K Sell
3,074
-3,226
-51% -$936K 0.08% 181
2025
Q2
$1.76M Buy
6,300
+4,431
+237% +$1.26M 0.14% 150
2025
Q1
$582K Sell
1,869
-12
-0.6% -$3.54K 0.06% 254
2024
Q4
$490K Buy
1,881
+190
+11% +$56.4K 0.06% 266
2024
Q3
$545K Buy
+1,691
New +$553K 0.08% 238

Other funds holding AMGN

Signal Advisors Wealth's AMGN Position: Q1 2026 in Review

Signal Advisors Wealth reduced its Amgen (AMGN) stake by 9.1% in Q1 2026, selling an estimated $74.2K and leaving 2,075 shares worth $730K. The position accounts for 0.05% of the portfolio, ranked #302.

Signal Advisors Wealth first reported a position in AMGN in Q3 2024 and has held it in 7 quarters since. The position peaked at $1.76M in Q2 2025. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Signal Advisors Wealth held 2,075 shares of Amgen worth $730K as of Q1 2026.
  • Signal Advisors Wealth sold 208 Amgen shares in Q1 2026, an estimated $74.2K.
  • Amgen made up 0.05% of Signal Advisors Wealth's portfolio in Q1 2026, its #302 holding.
  • Signal Advisors Wealth first reported a position in Amgen in Q3 2024 and has held it in 7 quarters since.
  • Signal Advisors Wealth's Amgen position peaked at $1.76M in Q2 2025.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Signal Advisors Wealth's 13F filing for Q1 2026, filed 17 Apr 2026.